Ali M Harandi | Lab Head, Dpt Of Microbiology And Immunology
University of Gothenburg

Dr. Ali Harandi is currently affiliated to Sahlgrenska Academy at University of Gothenburg in Sweden and holds a visiting faculty position at Vaccine Evaluation Center, University of British Columbia in Canada. Dr. Harandi was awarded the prestigious Heine-Medin medal by European Society for Clinical Virology in recognition of his contribution to the filed. He has participated in the leadership of several EU-funded R&D projects focused on development of vaccines against infectious diseases, and has served as expert advisor on vaccine to several European and international Philanthropic and non-profit organisations and funding agencies.

Appearances:

Day 1 - November 28 @ 10:10

Keynote Panel: Navigating the future of RSV Vaccines & Therapies: Tailoring Approaches from Maternal to Adults

Now there are vaccines available, what is the right approach for adults vs infants & maternal?
What is the optimal recommendation for use of different technologies based on the epidemiology of the disease?
Practical issues, health economics & policy considerations
Cost-effectiveness challenges
Remaining needs in older adults; how to protect in the second season and beyondHow to combat vaccine fatigue with new combinations and other approaches
The ecosystem of respiratory tract infections in the absence of RSV

Moderator: Ali M Harandi, Lab Head, Dpt Of Microbiology And Immunology, University of Gothenburg

Alejandro Cane, VP, US/IDM Vaccines and Antivirals Medical and Scientific Affairs Lead, Pfizer